What were the 30-day outcomes for the compassionate-use experience in North America with a transcatheter heart valve (THV) device dedicated to the treatment of aortic regurgitation (AR)?
Artificial intelligence (AI) and machine learning may play a future role in syncope management, but technical challenges as well as medicolegal and ethical concerns remain, according to a recent JACC: Advances multidisciplinary collaborative statement published May 10 in JACC: Advances.